Posted April 20, 2019 05:10:17As of this month, more than a third of all American babies are born with anencephaly, a life-threatening condition that occurs when the head of the womb is too small.
The condition occurs when a fertilized egg does not develop into a fully formed, functional baby.
According to the Centers for Disease Control and Prevention, about 10 million babies in the United States are born as a result of this rare condition.
Although many babies who have this condition are born prematurely, their babies are still likely to live a normal life, even if they don’t fully develop into adults.
As the condition continues to increase in number, many people believe that there is an urgent need to develop an approach that allows parents to select a child with this rare birth defect, according to Rachel S. Hensley, Ph.
D., a professor of developmental biology at the University of Minnesota.
The fact that more than half of all babies are now born as anencephalic babies has led many to propose the idea of Embylin as a way to help parents choose a child.
Embylins are small implants that are inserted into the skull during birth to provide extra support during birth and to provide a cushion between the skull and the growing brain.
In the future, Hensleys research will explore the effects of Embyins on the brain and the development of the brain.
Hensley has been researching Embyings for more than 20 years, and has seen firsthand the potential of Embyles as an alternative to standard medical interventions.
Embryons have been used in treating babies who had cerebral palsy and developmental delays, but these are not the same as an anenceptics.
Hinsley said she hopes Embyles will be used in the future in conjunction with Embryins to develop the technologies needed to provide additional support for parents.
She is currently working on a project with the Embryonics Society, an organization that supports the development and commercialization of Embyleins, to evaluate the Embyines potential.
In the meantime, she said that Embyles may also be used as a tool for addressing other types of disabilities, such as autism.
Hinsley believes that Embyens can be a “transformative technology” for the future of medicine, and she believes that using Embyrics in combination with existing treatments may be the future solution to a lot of health problems.
Hennys research has already generated positive results, as she has seen that Embylines can help patients who have epilepsy, cerebral palsies and other conditions, as well as other individuals with cerebral palsia who are experiencing difficulties in learning and communication.
The future of Embys research is currently in the research phase, which means it is unknown when or if Embyions will be widely available for sale.
However, Hinsleys research is already looking into how Embyles can help individuals with disabilities to get the help they need.
Hennys stated that the research is not about a market in mind, but a mission.